✦ LIBER ✦

Prospective phase II trial of sorafenib combined with doxorubicin eluting bead-transarterial chemoembolization for patients with unresectable hepatocellular carcinoma: efficacy analysis

✍ Scribed by Feng, A.; Reyes, D.; Kamel, I.; Gowdra Halappa, V.; Corona Villalobos, C.; Cosgrove, D.; Bhagat, N.; Hebert, J.; Wahlin, T.; Foltz, J.; Pawlik, T.; Geschwind, J.H.

Book ID: 122539820
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 44 KB
Volume: 24
Category: Article
ISSN: 1051-0443
DOI: 10.1016/j.jvir.2013.01.154

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Abstract No. 4: Phase II trial of sorafe

Abstract No. 4: Phase II trial of sorafenib combined with doxorubicin eluting bead-transarterial chemoembolization for patients with unresectable hepatocellular carcinoma: Interim efficacy analysis

✍ Reyes, D.; Azad, N.; Koteish, A.; Kamel, I.; Hamilton, J.; Pawlik, T.; Choti, M. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 87 KB

Abstract No. 141: Phase II trial of sora

Abstract No. 141: Phase II trial of sorafenib combined with doxorubicin eluting bead-transarterial chemoembolization for patients with unresectable hepatocellular carcinoma: Interim safety analysis

✍ Reyes, D.; Azad, N.; Koteish, A.; Kamel, I.; Hamilton, J.; Georgiades, C.; Pawli 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Phase II Trial of Sorafenib Combined Wit

Phase II Trial of Sorafenib Combined With Concurrent Transarterial Chemoembolization With Drug-Eluting Beads for Hepatocellular Carcinoma

✍ Pawlik, T. M.; Reyes, D. K.; Cosgrove, D.; Kamel, I. R.; Bhagat, N.; Geschwind, 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 181 KB

Safety and Efficacy of Doxorubicin Drug-

Safety and Efficacy of Doxorubicin Drug-eluting Bead Transarterial Chemoembolization in Patients with Advanced Hepatocellular Carcinoma

✍ Prajapati, Hasmukh J.; Dhanasekaran, Renumathy; El-Rayes, Bassel F.; Kauh, John 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 106 KB

Phase II study of concurrent transarteri

Phase II study of concurrent transarterial chemoembolization and sorafenib in patients with unresectable hepatocellular carcinoma

✍ Joong-Won Park; Young Hwan Koh; Hyun Beom Kim; Hwi Young Kim; Sangbu An; Joon-Il 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 839 KB

Abstract No. 142: Single centre phase II

Abstract No. 142: Single centre phase II trial of transarterial chemoembolization with drug eluting beads for patients with unresectable hepatocellular carcinoma: Initial experience in the USA

✍ Reyes, D.; Vossen, J.A.; Kamel, I.; Azad, N.; Wahlin, T.; Torbenson, M.; Choti, 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 132 KB